+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Activin-A Market by Type (Activin A Human, Activin A Mouse/ Rat), Application (Academic Research, Commercial Research) - Forecast 2024-2030

  • PDF Icon

    Report

  • 182 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5305483
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Activin-A Market size was estimated at USD 262.80 million in 2023, USD 287.73 million in 2024, and is expected to grow at a CAGR of 9.57% to reach USD 498.54 million by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Activin-A Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Activin-A Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Activin-A Market, highlighting leading vendors and their innovative profiles. These include Ajinomoto Co., Inc., Ansh Labs, LLC, Bio-Techne Corporation, BioLegend, Inc., Cell Guidance Systems LLC, CellGenix GmbH, Enzo Life Sciences, Inc., Merck KGaA, Miltenyi Biotec, Inc., PeproTech, Inc., Proteintech Group Inc., Qkine Ltd., RayBiotech, Inc., STEMCELL Technologies Inc., StemRD Inc., and Thermo Fisher Scientific Inc.

Market Segmentation & Coverage

This research report categorizes the Activin-A Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Activin A Human
    • Activin A Mouse/ Rat
  • Application
    • Academic Research
    • Commercial Research
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

  1. What is the market size and forecast of the Activin-A Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Activin-A Market?
  3. What are the technology trends and regulatory frameworks in the Activin-A Market?
  4. What is the market share of the leading vendors in the Activin-A Market?
  5. Which modes and strategic moves are suitable for entering the Activin-A Market?

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Purchase of this report includes 1 year online access with quarterly updates

Purchase of this report includes 1 year online access with quarterly updates

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Activin-A Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising demand for cell therapy
5.1.1.2. Benefits provided by activin A such as mesoderm induction, neural cell differentiation, bone remodeling, hematopoiesis
5.1.2. Restraints
5.1.2.1. High cost of manufacturing process
5.1.3. Opportunities
5.1.3.1. Broad range of sub-indications and available drug targets
5.1.3.2. Increasing advancements in the production process
5.1.4. Challenges
5.1.4.1. Probable side effects due to consumption of activin A
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Activin-A Market, by Type
6.1. Introduction
6.2. Activin A Human
6.3. Activin A Mouse/ Rat
7. Activin-A Market, by Application
7.1. Introduction
7.2. Academic Research
7.3. Commercial Research
8. Americas Activin-A Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Activin-A Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Activin-A Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player
12. Competitive Portfolio
12.1. Key Company Profiles
12.1.1. Ajinomoto Co., Inc.
12.1.2. Ansh Labs, LLC
12.1.3. Bio-Techne Corporation
12.1.4. BioLegend, Inc.
12.1.5. Cell Guidance Systems LLC
12.1.6. CellGenix GmbH
12.1.7. Enzo Life Sciences, Inc.
12.1.8. Merck KGaA
12.1.9. Miltenyi Biotec, Inc.
12.1.10. PeproTech, Inc.
12.1.11. Proteintech Group Inc.
12.1.12. Qkine Ltd.
12.1.13. RayBiotech, Inc.
12.1.14. STEMCELL Technologies Inc.
12.1.15. StemRD Inc.
12.1.16. Thermo Fisher Scientific Inc.
12.2. Key Product Portfolio
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
List of Figures
FIGURE 1. ACTIVIN-A MARKET RESEARCH PROCESS
FIGURE 2. ACTIVIN-A MARKET SIZE, 2023 VS 2030
FIGURE 3. ACTIVIN-A MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. ACTIVIN-A MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. ACTIVIN-A MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. ACTIVIN-A MARKET DYNAMICS
FIGURE 7. ACTIVIN-A MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. ACTIVIN-A MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. ACTIVIN-A MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 10. ACTIVIN-A MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS ACTIVIN-A MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS ACTIVIN-A MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES ACTIVIN-A MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES ACTIVIN-A MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC ACTIVIN-A MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC ACTIVIN-A MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ACTIVIN-A MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA ACTIVIN-A MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ACTIVIN-A MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 20. ACTIVIN-A MARKET SHARE, BY KEY PLAYER, 2023

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Ajinomoto Co., Inc.
  • Ansh Labs, LLC
  • Bio-Techne Corporation
  • BioLegend, Inc.
  • Cell Guidance Systems LLC
  • CellGenix GmbH
  • Enzo Life Sciences, Inc.
  • Merck KGaA
  • Miltenyi Biotec, Inc.
  • PeproTech, Inc.
  • Proteintech Group Inc.
  • Qkine Ltd.
  • RayBiotech, Inc.
  • STEMCELL Technologies Inc.
  • StemRD Inc.
  • Thermo Fisher Scientific Inc.

Methodology

Loading
LOADING...

Table Information